【摘要】 脓毒症是宿主对感染的失调反应，常导致危及生命的器官功能障碍，而急性呼吸窘迫综合征(ARDS)是脓毒症最常见的并发症之一。近年来，随着儿童脓毒症及ARDS定义和诊断标准的更新，儿童脓毒症相关ARDS的识别和治疗成为临床医学研究的热点。本文将结合近些年来学术界的新进展对一些新型生物标志物及治疗策略进行总结，以期为医师在临床诊治过程中提供理论依据。

    【关键词】 儿童 脓毒症 急性呼吸窘迫综合征 发病机制 临床特征 新型生物标记物

    Progress in Early Identification and Treatment of Sepsis-related Acute Respiratory Distress Syndrome in Children/Zainaifu Naibijiang， Aitunike Shamawati， Abulaiti Abuduhaer. //Medical Innovation of China， 2024， 21(36)： -175

    [Abstract] Sepsis is the host's maladjusted response to infection， which often leads to life-threatening organ dysfunction. Acute respiratory distress syndrome (ARDS) is one of the most common complications of sepsis. In recent years， with the update of the definition and diagnostic criteria of ARDS in children， the identification and treatment of sepsis-related ARDS in children have become the focus of clinical medical research. In this paper， some new biomarkers and treatment strategies will be summarized in combination with the new progress in academic circles in recent years， in order to provide theoretical basis for doctors in clinical diagnosis and treatment. ......